香港联合交易所有限公司
(香港交易及结算所有限公司全资附属公司)
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
ANNOUNCEMENT
In relation to the matter of
Tianhe Chemicals Group Limited
(Incorporated in the British Virgin Islands with limited liability)
(Stock Code: 1619)
Cancellation of listing
The Stock Exchange of Hong Kong Limited (the “Exchange”) announced that with effect from 9:00 am on 11 June 2020, the listing of the shares of Tianhe Chemicals Group Limited (the “Company”) will be cancelled under Rule 6.01A.
|
The Exchange announces that the listing of the Company's shares will be cancelled with effect from 9:00 am on 11 June 2020 under Rule 6.01A.
Trading in the Company’s shares has been suspended since 26 March 2015.
On 25 May 2017, the Securities and Futures Commission (the “SFC”) exercised its power under section 8(1) of the Securities and Futures (Stock Market Listing) Rules to direct the Exchange to suspend dealings in the shares of the Company.
Under Rule 6.01A, the Exchange may delist the Company if trading does not resume by 31 July 2019. After consultation with the SFC, the Exchange agreed to withhold delisting the Company until 31 October 2019.
The Company failed to fulfil all the resumption conditions imposed by the Exchange and resume trading in its shares by 31 October 2019. On 20 December 2019, the Listing Committee decided to cancel the listing of the Company’s shares on the Exchange under Rule 6.01A.
On 3 January 2020, the Company sought a review of the Listing Committee’s decision by the Listing Review Committee. On 29 May 2020, the Listing Review Committee upheld the decision of the Listing Committee to cancel the Company’s listing. Accordingly, the Exchange will cancel the Company’s listing with effect from 9:00 am on 11 June 2020.
The Exchange has requested the Company to publish an announcement on the cancellation of its listing.
The Exchange advises shareholders of the Company who have any queries about the implications of the delisting to obtain appropriate professional advice.
Ends